ℹ️ This is the case information for the doctor.
Name
Julia Baxter
Age
48
Address
25 Park Avenue, Warminster, Wiltshire
Social history
Past history
Investigation results
Readomgs from 3 months prior
Medication
Booking note
Ongoing menopausal symptoms despite Evorel
ℹ️ This is the information for the person role playing the patient.
Name
Julia Baxter
Age
48
Address
25 Park Avenue, Warminster, Wiltshire
Social history
Past history
Medication
“I’m hoping you can help. I’ve been on the menopause patches but I’m still getting some of the hot flushes and the tiredness – I don’t feel quite right, and it’s affecting work and everything.”
She leaves the consultation feeling reassured if she receives:
ℹ️ To mark data gathering & diagnosis select from the descriptors below.
Positive descriptors
Negative descriptors
Data gathering is systematic and targeted, ensuring patient safety:
Data gathering is systematic and targeted, ensuring patient safety:
Uses existing information and considers the wider context:
Uses existing information and considers the wider context:
Establishes the presence or absence of relevant red flags:
Establishes the presence or absence of relevant red flags:
Places the information in its psychosocial context:
Places the information in its psychosocial context:
Collects relevant information to ensure appropriate endometrial protection and safe prescribing:
Collects relevant information to ensure appropriate endometrial protection and safe prescribing:
ℹ️ To mark clinical management & medical complexity select from the descriptors below.
Positive descriptors
Negative descriptors
Offers management options that are safe and appropriate:
Offers management options that are safe and appropriate:
Prescribes safely considering local and national guidance:
Prescribes safely considering local and national guidance:
Tailors management to circumstances, priorities and preferences:
Tailors management to circumstances, priorities and preferences:
Arranges appropriate follow-up:
Arranges appropriate follow-up:
Manages uncertainty, including the patient’s uncertainty:
Manages uncertainty, including the patient’s uncertainty:
ℹ️ To mark relating to others select from the descriptors below.
Positive descriptors
Negative descriptors
Communicates in a person-centred way:
Communicates in a person-centred way:
Gives appropriate regard to consent, confidentiality and safety:
Gives appropriate regard to consent, confidentiality and safety:
Demonstrates empathy and willingness to help:
Demonstrates empathy and willingness to help:
Works collaboratively with the wider healthcare team:
Works collaboratively with the wider healthcare team:
Checks the patient’s understanding of the consultation and agreed plan:
Checks the patient’s understanding of the consultation and agreed plan:
ℹ️ Insights from the examiner
Case at a glance
Julia Baxter is 48 and has been using Evorel Sequi for six months. She has had some improvement, but continues to experience:
Julia is anxious about HRT safety because her mother developed breast cancer at the age of 82.
This consultation should not be treated as a simple request to “increase the patch”. It requires a targeted menopause review, assessment of red flags and risk factors, consideration of endometrial protection, and sensitive exploration of urogenital symptoms.
GP trainee performance focus
A strong GP trainee should demonstrate the ability to:
What this case is testing
Patient priorities and concerns
Julia’s priorities may include:
Central challenge
The central challenge is to avoid treating this as a straightforward “increase the patch” request.
The clinician needs to:
Must-not-miss issue or diagnosis
The key must-not-miss issues are:
Red flags or high-risk features
safety features to assess include:
Common GP trainee pitfalls
What good looks like
A strong consultation is structured, sensitive and safety-focused. The trainee validates Julia’s ongoing symptoms, checks safety issues, explains options clearly and agrees a plan that addresses both systemic and vaginal symptoms.
“You’ve had some improvement with HRT, but you still have hot flushes, brain fog and vaginal symptoms. Before changing the dose, I’d like to check bleeding, breast symptoms and how the patches are working for you, then we can discuss the safest options.”
Learner checkpoint
Have I reviewed symptoms, bleeding, risk factors and endometrial protection before changing HRT?
Start with an open question
Begin with Julia’s experience of treatment.
“Could you talk me through what improved after starting the patches, and what still feels difficult?”
This helps clarify whether the main issue is persistent vasomotor symptoms, sleep disruption, cognitive symptoms, vaginal symptoms, anxiety about risk, or a combination.
Time-efficient data gathering
Explore:
High-yield questions
Vasomotor symptoms
Ask about:
Cognitive and general symptoms
Explore:
Urogenital symptoms
Ask sensitively about:
Normalise the topic:
“You mentioned feeling embarrassed about the dryness. It’s a very common menopause symptom, and it’s something we can talk about and treat.”
Bleeding and safety assessment
Before changing HRT, clarify:
Use signposting:
“Before we change anything, I’d like to check a few safety questions, including bleeding, breast symptoms and headaches.”
HRT use and adherence
Clarify:
Personal and family risk assessment
Explore:
Clarify that her mother’s breast cancer at 82 is important to Julia’s anxiety, but is not the same as Julia having a personal history of breast cancer.
Functional, psychosocial or contextual assessment
Julia is managing:
Acknowledge the burden:
“It sounds as though you’re managing a lot, and these symptoms are making an already busy life much harder.”
Explore ideas, concerns and expectations
Julia’s goals may include:
Ask:
“What would you most like to be different after today’s review?”
Recognise and respond to cues
Julia may appear tired, composed and anxious rather than confrontational. She may not volunteer vaginal symptoms unless the topic is normalised.
If she raises breast-cancer concerns:
“Your concern about breast cancer makes complete sense given what happened to your mum. Let’s go through the risks in a balanced way.”
If she appears embarrassed about sexual symptoms:
“Lots of women find these symptoms hard to bring up, but they are common and treatable.”
Useful consultation phrases
“The fact that some symptoms have improved suggests the treatment is having an effect, but we need to look at what remains troublesome.”
“Increasing oestrogen may help, but we should not increase it on its own. We need the right progestogen as well to protect the womb lining.”
“Vaginal oestrogen can be used alongside your patch and is very helpful for dryness and discomfort.”
“HRT is not entirely risk-free, so the decision should be based on your individual risks, symptoms and preferences.”
Consultation flow and signposting
Summarising and checking understanding
Before management, summarise:
“You’ve had some improvement with HRT, but you still have hot flushes, brain fog and vaginal symptoms. You haven’t described abnormal bleeding or pelvic pain, and your main concern is whether it is safe to change the treatment.”
Check:
Data gathering self-check
Before changing HRT, the trainee should know:
Assessment domain mapping
Data gathering
Clinical management
Relating to others
Prioritised differential diagnosis or clinical reasoning
The relevant differential includes:
Normal FBC and TSH results reduce, but do not completely remove, the likelihood of anaemia or thyroid disease contributing to tiredness and brain fog.
Clinical reasoning script
“Some of your symptoms improving tells us the HRT is doing something, but you’re still significantly affected. We need to decide whether to adjust the systemic HRT, while making sure the womb lining remains protected, and you brest cancer risk is low. Vaginal symptoms often need treatment with creams.”
Red flags and risk assessment
Before modifying HRT, assess for:
These should influence whether treatment is modified, reviewed or investigated before proceeding.
Decision points
Key decisions include:
Management priority
The management priority is to improve Julia’s persistent symptoms safely, while addressing:
Management options
1. Optimise systemic HRT
Consider:
Ensure adequate progestogenic endometrial protection is maintained.
2. Treat vaginal symptoms directly
Offer:
Explain that vaginal symptoms may not fully respond to increasing systemic HRT alone.
3. Review safety and monitoring
Review:
Explain expected monitoring and when Julia should seek review.
4. Discuss breast-cancer risk carefully
Discuss:
Frame the discussion honestly:
“HRT is not entirely risk-free, but the decision is about balancing your symptoms, your personal risk factors and what matters most to you.”
5. Consider VTE and cardiovascular risk
Discuss:
Transdermal HRT as advantageous for VTE risk. Explain this as part of the overall risk-benefit discussion without implying it eliminates risk.
6. Support wider wellbeing
Address:
Ask whether Julia has enough support with caring for her father and whether additional help would be useful.
Personalised plan
Link the plan to Julia’s life:
Example phrase:
“Let’s choose a plan that improves your symptoms but also keeps safety checks built in, because I can hear how important that is for you.”
A personalised plan may include:
Shared decision-making
Involve Julia in choosing between options.
Discuss:
Check understanding:
“Can I check what you understand about the options, and which one feels most acceptable to you?”
Safety-netting
Advise Julia to seek review promptly if she develops:
Make sure she knows who to contact and when.
Documentation points
Document:
Common unsafe management plans
Avoid:
Follow-up and coordination with other professionals
Arrange follow-up to review:
Consider support from:
Learner checkpoint
Can the plan realistically help Julia function at work, maintain intimacy, manage caring responsibilities and feel safe about HRT?
Relevant guidance areas
This includes guidance and resources on:
NICE guidance
BNF references
RCGP and SCA resources
Relevant research or educational references
Additional clinical resources mentioned
Key principles to remember
Transferable learning for future cases
In HRT review consultations:
Supervisor or examiner lens
A supervisor or examiner is likely to look for:
Final learner takeaway
Persistent menopausal symptoms need a structured HRT review: check safety, protect the endometrium, treat vaginal symptoms directly and tailor the plan to the patient’s life.
